Authors:
NIELAND JD
LOVISCEK K
KONO K
ALBAIN KS
MCCALL AR
POTKUL RK
FISHER SG
VELDERS MP
PETERSSON M
KIESSLING T
KAST WM
Citation: Jd. Nieland et al., PBLS OF EARLY BREAST-CARCINOMA PATIENTS WITH A HIGH NUCLEAR GRADE TUMOR UNLIKE PBLS OF CERVICAL-CARCINOMA PATIENTS DO NOT SHOW A DECREASED TCR-ZETA EXPRESSION BUT ARE FUNCTIONALLY IMPAIRED, Journal of immunotherapy, 21(4), 1998, pp. 317-322
Authors:
LAU DH
CROWLEY JJ
HAZUKA MB
ALBAIN KS
LEIGH B
FLETCHER WS
LANIER KS
KEISER WL
LIVINGSTON RB
Citation: Dh. Lau et al., SOUTHWEST-ONCOLOGY-GROUP PHASE-II TRIAL OF CONCURRENT CARBOPLATIN, ETOPOSIDE, AND RADIATION FOR POOR-RISK STAGE-III NON-SMALL-CELL LUNG-CANCER, Journal of clinical oncology, 16(9), 1998, pp. 3078-3081
Authors:
WOZNIAK AJ
CROWLEY JJ
BALCERZAK SP
WEISS GR
SPIRIDONIDIS CH
BAKER LH
ALBAIN KS
KELLY K
TAYLOR SA
GANDARA DR
LIVINGSTON RB
Citation: Aj. Wozniak et al., RANDOMIZED TRIAL COMPARING CISPLATIN WITH CISPLATIN PLUS VINORELBINE IN THE TREATMENT OF ADVANCED NON-SMALL-CELL LUNG-CANCER - A SOUTHWEST-ONCOLOGY-GROUP STUDY, Journal of clinical oncology, 16(7), 1998, pp. 2459-2465
Citation: Ks. Albain, LUNG-CANCER IN WOMEN COMPARED WITH MEN - STAGE, TREATMENT, AND SURVIVAL, The Annals of thoracic surgery, 66(4), 1998, pp. 1143-1144
Authors:
ALBAIN KS
GREEN SR
LICHTER AS
HUTCHINS LF
WOOD WC
HENDERSON IC
INGLE JN
OSULLIVAN J
OSBORNE CK
MARTINO S
Citation: Ks. Albain et al., INFLUENCE OF PATIENT CHARACTERISTICS, SOCIOECONOMIC-FACTORS, GEOGRAPHY, AND SYSTEMIC RISK ON THE USE OF BREAST-SPARING TREATMENT IN WOMEN ENROLLED IN ADJUVANT BREAST-CANCER STUDIES - AN ANALYSIS OF 2 INTERGROUP TRIALS, Journal of clinical oncology, 14(11), 1996, pp. 3009-3017
Authors:
ALBAIN KS
RUSCH VW
CROWLEY JJ
RICE TW
TURRISI AT
WEICK JK
LONCHYNA VA
PRESANT CA
MCKENNA RJ
GANDARA DR
FOSMIRE H
TAYLOR SA
STELZER KJ
BEASLEY KR
LIVINGSTON RB
Citation: Ks. Albain et al., CONCURRENT CISPLATIN ETOPOSIDE PLUS CHEST RADIOTHERAPY FOLLOWED BY SURGERY FOR STAGES IIIA(N2) AND IIIB NON-SMALL-CELL LUNG-CANCER - MATURERESULTS OF SOUTHWEST-ONCOLOGY-GROUP PHASE-II STUDY-8805/, Journal of clinical oncology, 13(8), 1995, pp. 1880-1892
Authors:
ALBAIN KS
LIU PY
HANTEL A
POPLIN EA
OTOOLE RV
WADE JL
MADDOX AM
ALBERTS DS
Citation: Ks. Albain et al., A PHASE-II TRIAL OF PIROXANTRONE IN ADVANCED OVARIAN-CARCINOMA AFTER FAILURE OF PLATINUM-BASED CHEMOTHERAPY - SOUTHWEST-ONCOLOGY-GROUP STUDY-8904, Gynecologic oncology, 57(3), 1995, pp. 407-411
Authors:
RUSCH VW
ALBAIN KS
CROWLEY JJ
RICE TW
LONCHYNA V
MCKENNA R
STELZER K
LIVINGSTON RB
Citation: Vw. Rusch et al., NEOADJUVANT THERAPY - A NOVEL AND EFFECTIVE TREATMENT FOR STAGE IIIB NONSMALL CELL LUNG-CANCER, The Annals of thoracic surgery, 58(2), 1994, pp. 290-295
Authors:
ALBAIN KS
CROWLEY JJ
HUTCHINS L
GANDARA D
OBRYAN RM
VONHOFF DD
GRIFFIN B
LIVINGSTON RB
Citation: Ks. Albain et al., PREDICTORS OF SURVIVAL FOLLOWING RELAPSE OR PROGRESSION OF SMALL-CELLLUNG-CANCER - SOUTHWEST-ONCOLOGY-GROUP STUDY 8605 REPORT AND ANALYSISOF RECURRENT DISEASE DATA-BASE, Cancer, 72(4), 1993, pp. 1184-1191